Gabapentin therapy for ocular opsoclonus-myoclonus restores eye movement communication in a patient with a locked-in syndrome

Neurorehabilitation and Neural Repair

Volumn 24, Issue 5, 2010, Pages 493-494

  Pistoia, Francesca ^a,b   Sarà, Marco ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Gabapentin; Locked in; Rehabilitation

Indexed keywords

GABAPENTIN;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BLINKING; BRAIN INFARCTION; CASE REPORT; DRUG DOSE INCREASE; EYE MOVEMENT; FEMALE; HUMAN; LOCKED IN SYNDROME; NONVERBAL COMMUNICATION; OCCLUSIVE CEREBROVASCULAR DISEASE; OPSOCLONUS MYOCLONUS SYNDROME; PARALYSIS; QUALITY OF LIFE; REHABILITATION CARE; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AMINES; ANTICONVULSANTS; CEREBRAL INFARCTION; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MAGNETIC RESONANCE IMAGING; OCULAR MOTILITY DISORDERS; OPSOCLONUS-MYOCLONUS SYNDROME; PONS; QUADRIPLEGIA;

EID: 77953227330     PISSN: 15459683     EISSN: 15526844     Source Type: Journal    
DOI: 10.1177/1545968309353330     Document Type: Article

References (5)

1. Dumas A. The Count of Monte Cristo. London, UK: Word-worth; 1997.
2. Zola E. Therese Raquin. Paris, France: Gallimard ; 1979.
3. Daly JJ, Wolpaw JR Brain-computer interfaces in neurological rehabilitation. Lancet Neurol. 2008 ; 7: 1032-1043.
4. Tijssen CC, Ter Bruggen JP Locked-in syndrome associated with ocular bobbing. Acta Neurol Scand. 1986 ; 73: 444-446.
5. Moretti R., Torre P., Antonello RM, Nasuelli D., Cazzato G. Opsoclonus-myoclonus syndrome: gabapentin as a new therapeutic proposal. Eur J Neurol. 2000 ; 7: 455-456.